Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
Authors:
Open Access
- 1 June 2011
- journal article
- review article
- Published by Taylor & Francis in Substance Abuse and Rehabilitation
- Vol. 2, 113-123
Abstract
Peer reviewed article authored by (Mannelli P, Peindl K, Wu LT). Read article or submit your manuscript for publishing.Keywords
This publication has 98 references indexed in Scilit:
- CLINICAL STUDY: Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trialAddiction Biology, 2009
- Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in ratsBehavioural Pharmacology, 2008
- Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant programSubstance Abuse Treatment, Prevention, and Policy, 2007
- Deficit of circulating stem – progenitor cells in opiate addiction: a pilot studySubstance Abuse Treatment, Prevention, and Policy, 2007
- Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin DependenceJournal of Psychoactive Drugs, 2007
- Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatmentDrug and Alcohol Review, 2007
- Predictors of Retention in Naltrexone Maintenance for Opioid Dependence: Analysis of a Stage I TrialThe American Journal on Addictions, 2006
- Safety of High-Dose Naltrexone TreatmentClinical Neuropharmacology, 2006
- Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patientsLife Sciences, 2005
- Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawalJournal of Clinical Pharmacy and Therapeutics, 2000